High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes
Launched by KENNESAW STATE UNIVERSITY · Oct 4, 2022
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of exercise program called high intensity body-weight circuit training (HIBC) to see how it might help middle-aged people manage their type 2 diabetes. The study aims to find out if this type of training can improve health markers, body composition (like muscle and fat levels), and overall fitness in those recently diagnosed with type 2 diabetes. With type 2 diabetes becoming more common, the results could provide a valuable exercise option for better management of this condition.
To participate, you need to be between the ages of 18 and 65, have been diagnosed with type 2 diabetes in the past year, and have certain blood sugar levels (an HbA1c of 6% or higher). You should not be on any insulin treatments or medications for diabetes, and you should not have been involved in a physical exercise program in the last six months. If you join the study, you can expect to engage in this exercise program and contribute to important research that could help many others with type 2 diabetes. It's also important to know that people with certain heart, lung, or kidney issues, or those who smoke, cannot participate in this trial for safety reasons.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Recent diagnosed of type 2 diabetes (T2DM) (within a year) \* HbA1c of 6% or higher
- • Non-insulin dependent
- • No medicinal treatment
- • Not currently undergoing a physical activity program in the last six months
- • Received written medical clearance from overseeing physician
- Exclusion Criteria:
- • Those who have undergone any revascularization procedure
- • Diagnosed with or symptomatic of any renal, pulmonary, or cardiovascular disease (CVD)
- • Diagnosed cognitive dysfunction
- • Current smoker
About Kennesaw State University
Kennesaw State University (KSU) is a leading public research institution located in Kennesaw, Georgia, dedicated to advancing education, innovation, and community engagement. As a prominent sponsor of clinical trials, KSU leverages its extensive academic resources and interdisciplinary expertise to conduct rigorous research aimed at improving health outcomes. The university fosters collaboration among faculty, students, and healthcare professionals, ensuring that its clinical studies are grounded in scientific integrity and ethical practices. KSU is committed to enhancing the understanding of various medical conditions and contributing to the development of effective interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kennesaw, Georgia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials